Formulation of lipid core nanocapsules

Colloids and Surfaces A: Physicochemical and Engineering Aspects

Volumn 375, Issue 1-3, 2011, Pages 200-208

  Venturini, Cristina G ^a   Jäger, Eliézer ^a   Oliveira, Catiuscia P ^a   Bernardi, Andressa ^a   Battastini, Ana M O ^a   Guterres, Silvia S ^a   Pohlmann, Adriana R ^a  

^a FEDERAL UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

Author keywords

Control of assembly; Density gradient; Indomethacin ethyl ester; Lipid core nanocapsules; Multiple light scattering; Polymeric nanoparticles

Indexed keywords

EMULSIFICATION; ESTERIFICATION; ESTERS; GLYCEROL; LIGHT SCATTERING; NANOCAPSULES; NANOPARTICLES; REFRACTION; SCATTERING; SUSPENSIONS (FLUIDS); WALLS (STRUCTURAL PARTITIONS);

ANALYTICAL APPROACH; AQUEOUS SUSPENSIONS; DENSITY GRADIENTS; DRUG CARRIER; FUNCTION OF TIME; INDOMETHACIN; LASER DIFFRACTOMETRY; LIGHT SCATTERING MEASUREMENT; LIPID CORES; MULTIPLE LIGHT SCATTERING; NANOCARRIERS; NANOEMULSION; OIL CONCENTRATION; OIL CORE; ORGANIC PHASE; POLYMERIC NANOPARTICLES; POLYSORBATE 80; TRIACYLGLYCEROLS; VESICULAR STRUCTURE;

POLYMERS;

DRUG CARRIER; LIPID EMULSION; MEDIUM CHAIN TRIACYLGLYCEROL; NANOCAPSULE; NANOCARRIER; NANOPARTICLE; POLYESTER; POLYSORBATE 80; SORBITAN STEARATE; TRIACYLGLYCEROL;

ARTICLE; COLLOID; DENSITY GRADIENT; DRUG FORMULATION; LIGHT SCATTERING; MOLECULAR MODEL; NANOEMULSION; POLYMERIZATION; PRIORITY JOURNAL; SEDIMENTATION; SUSPENSION;

EID: 78751626567     PISSN: 09277757     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.colsurfa.2010.12.011     Document Type: Article

References (46)

1. Owens E.D., Peppas A.N. Opsonization, biodistribution, and pharmacokinetics of polymeric nanoparticles. Int. J. Pharm. 2006, 307:93-102.
2. Kumari A., Yadav S.K., Yadav S.C. Biodegradable polymeric nanoparticles based drug delivery systems. Colloid Surf. B 2010, 75:1-18.
3. Bernardi A., Braganhol E., Jager E., Figueiro F., Edelweiss M.I., Pohlmann A.R., Guterres S.S., Battastini A.M.O. Indomethacin-loaded nanocapsules treatment reduces in vivo glioblastoma growth in a rat glioma model. Cancer Lett. 2009, 281:53-63.
4. Sutthanut K., Lu X., Jay M., Sripanidkulchai B. Solid lipid nanoparticles for topical administration of Kaempferia Parviflora extracts. J. Biomed. Nanotechnol. 2009, 5:224-232.
5. Bi R., Shao W., Wang Q., Zhang N. Solid lipid nanoparticles as insulin inhalation carriers for enhanced pulmonary delivery. J. Biomed. Nanotechnol. 2009, 5:84-92.
6. Oganesyan E.A., Miroshnichenko I.I., Vikhrieva N.S., Lyashenko A.A., Leshkov S.Y. Use of nanoparticles to increase the systemic bioavailability of trans-resveratrol. Pharm. Chem. J. 2010, 44:74-76.
7. Mora-Huertas C.E., Fessi H., Elaissari A. Polymer-based nanocapsules for drug delivery. Int. J. Pharm. 2010, 385:113-142.
8. Couvreur P., Barratt G., Fattal E., Legrand P., Vauthier C. Nanocapsule technology: a review. Crit. Rev. Therap. Drug Carrier Syst. 2002, 19:99-134.
9. Soppimath K.S., Aminabhavi T.M., Kulkarni A.R., Rudziski W.E. Biodegradable polymeric nanoparticles as drug delivery devices. J. Control. Rel. 2001, 70:1-20.
10. Rao G.C.S., Kumar M.S., Mathivanan N., Rao M.E.B. Nanosuspensions as the most promising approach in nanoparticulate drug delivery systems. Pharmazie 2004, 59:5-9.
11. Reis C.P., Neufeld R.J., Ribeiro A.J., Veiga F. Nanoencapsulation II. Biomedical applications and current status of peptide and protein nanoparticulate delivery systems. Nanomed. Nanotechnol. Biol. Med. 2006, 2:53-65.
12. Jäger A., Stefani V., Guterres S.S., Pohlmann A.R. Physico-chemical characterization of nanocapsule polymeric wall using fluorescent benzazole probes. Int. J. Pharm. 2007, 338:297.
13. Pohlmann A.R., Weiss V., Mertins O., Silveira N.P., Guterres S.S. Spray-dried indomethacin-loaded polyesters nanocapsules and nanospheres: development, stability evaluation and nanostructure models. Eur. J. Pharm. Sci. 2002, 16:305-312.
14. Pohlmann A.R., Cruz L., Mezzalira G., Soares L.U., Silveira N.P., Guterres S.S. Structural model of polymeric nanospheres containing indomethacin ethyl ester and in vivo antiedematogenic activity. Int. J. Nanotechnol. 2007, 4:454-467.
15. Guterres S.S., Fessi H., Barrat G., Devissaguet J.-P., Puisieux F. Poly(d,l-lactide) nanocapsules containing diclofenac. I. Formulation and stability study. Int. J. Pharm. 1995, 13:57-63.
16. Jung T., Kamm W., Breitenbach A., Kaiserling E., Xiao J.X., Kissel T. Biodegradable nanoparticles for oral delivery of peptides: is there a role for polymers to affect mucosal uptake?. Eur. J. Pharm. Biopharm. 2000, 50:147-160.
17. Vila A., Sánchez A., Tobío M., Calvo P., Alonso M.J. Design of biodegradable particles for protein delivery. J. Control. Rel. 2002, 78:15-24.
18. Mu L., Seow P.H., Ang S.N., Feng S.S. Study on surfactant coating of polymeric nanoparticles for controlled delivery of anticancer drug. Colloid Polym. Sci. 2004, 283:58-65.
19. Pohlmann A.R., Soares L.U., Cruz L., Pesce da Silveira N., Guterres S.S. Alkaline hydrolysis as a tool to determine the association form of indomethacin in nanocapsules prepared with poly(e{open}-caprolactone). Curr. Drug Deliv. 2004, 1:103-110.
20. Cruz L., Soares L.U., Dalla Costa T., Mezzalira G., Silveira N.P., Guterres S.S., Pohlmann A.R. Diffusion and mathematical modeling of release profiles from nanocarriers. Int. J. Pharm. 2006, 313:198-205.
21. Poletto F.S., Jager E., Cruz L., Pohlmann A.R., Guterres S.S. The effect of polymeric wall on the permeability of drug-loaded nanocapsules. Mater. Sci. Eng. C 2008, 28:472-478.
22. Muller C.R., Schaffazick S.R., Pohlmann A.R., Freitas L.D., Silveira N.P., Costa T.D., Guterres S.S. Spray-dried diclofenac-loaded poly(epsilon-caprolactone) nanocapsules and nanospheres: preparation and physicochemical characterization. Pharmazie 2001, 56:864-867.
23. Cruz L., Schaffazick S.R., Dalla Costa T., Soares L.U., Mezzalira G., Silveira N.P., Schapoval E.E.S., Pohlmann A.R., Guterres S.S. Physico-chemical characterization and in vivo evaluation of indomethacin ethyl ester-loaded nanocapsules by PCS, TEM, SAXS, interfacial alkaline hydrolysis and antiedematogenic activity. J. Nanosci. Nanotechnol. 2006, 6:3154-3162.
24. Jäger E., Venturini C.G., Poletto F., Colome L.M., Pohlmann J.P.U., Bernardi A., Battastini A.M.O., Guterres S.S., Pohlmann A.R. Sustained release from lipid-core nanocapsules by varying the core viscosity and the particle surface area. J. Biomed. Nanotechnol. 2009, 5:130-140.
25. Roland I., Piel G., Delattre L., Evrard B. Systematic characterization of oil-in-water emulsions for formulation design. Int. J. Pharm. 2003, 263:85-94.
26. Buron H., Mengual O., Meunier G., Cayré I., Snabre P. Review optical characterization of concentrated dispersions: applications to laboratory analyses and on-line process monitoring and control. Polym. Int. 2004, 53:1205-1209.
27. Jores K., Mehnert W., Drechsler M., Bunjes H., Johann C., Mader K. Investigations on the structure of solid lipid nanoparticles (SLN) and oil-loaded solid lipid nanoparticles by photon correlation spectroscopy, field-flow fractionation and transmission electron microscopy. J. Control. Rel. 2004, 95:217-227.
28. Yegin B.A., Lamprecht A. Lipid nanocapsule size analysis by hydrodynamic chromatography and photon correlation spectroscopy. Int. J. Pharm. 2006, 320:165-170.
29. Mengual O., Meunier G., Cayre I., Puech K., Snabre P. Characterisation of instability of concentrated dispersions by a new optical analyser: the TURBISCAN MA 1000. Colloid Surf. A 1999, 152:111-123.
30. Mengual O., Meunier G., Cayre I., Puech K., Snabre P. TURBISCAN MA 2000: multiple light scattering measurement for concentrated emulsion and suspension instability analysis. Talanta 1999, 50:445-456.
31. Cattani V.B., Pohlmann A.R., Costa T.D. Pharmacokinetic evaluation of indomethacin ethyl ester-loaded nanocapsules. Int. J. Pharm. 2008, 363:214-216.
32. Cattani V.B., Fiel L.A., Jäger A., Jäger E., Colomé L.M., Uchoa F., Stefani V., Costa T.D., Guterres S.S., Pohlmann A.R. Lipid-core nanocapsules restrained the indomethacin ethyl ester hydrolysis in the gastrointestinal lumen and wall acting as mucoadhesive reservoirs. Eur. J. Pharm. Sci. 2010, 39:116-124.
33. Kalgutkar A.S., Marnett A.B., Crews B.C., Remmel R.P. Ester and amide derivatives of the nonsteroidal anti-inflammatory drug, indomethacin, as selective cyclooxygenase-2 inhibitors. J. Med. Chem. 2000, 43:2860-2870.
34. Xu R. Particle Characterization: Light Scattering Methods 2002, Kluwer, Miami.
35. Daoud-Mahammed S., Couvreur P., Gref R. Novel self-assembling nanogels: stability and lyophilisation studies. Int. J. Pharm. 2007, 332:185-191.
36. Mei Z., Chen H., Weng T., Yang Y., Yang X. Solid lipid nanoparticle and microemulsion for topical delivery of triptolide. J. Pharm. Biopharm. 2003, 56:189-196.
37. Calvo P., Sánchez A., Martinez J., López M.I., Calonge M., Pastor J.C., Alonso M.J. Polyester nanocapsules as new topical ocular delivery systems for cyclosporin A. Pharm. Res. 1996, 13:311-315.
38. Ferranti V., Marchais H., Chabenat C., Orecchioni A.M., Lafont O. Primidone-loaded poly-e{open}-caprolactone nanocapsules: incorporation efficiency and in vitro release profiles. Int. J. Pharm. 1999, 193:107-111.
39. Jackson J.K., Liang L.S., Hunter W.L., Reynolds M., Sandberg J.A., Springate C., Burt H.M. The encapsulation of ribozymes in biodegradable polymeric matrices. Int. J. Pharm. 2002, 243:43-55.
40. 3 factorial design. AAPS Pharm. Sci. Technol. 2004, 4:1-9.
41. Quintanar-Guerrero D., Fessi H., Allémann E., Doelker E. Influence of stabilizing agents and preparative variables on the formation of poly(d,l lactic acid) nanoparticles by an emulsification-diffusion technique. Int. J. Pharm. 1996, 143:133-141.
42. Gullapalli R.P., Sheth B.B. Influence of an optimized non-ionic emulsifier blend on properties of oil-in-water emulsions. Eur. J. Pharm. Biopharm. 1999, 48:233-238.
43. Lim S.-J., Kim C.-K. Formulation parameters determining the physicochemical characteristics of solid lipid nanoparticles loaded with all-trans retinoic acid. Int. J. Pharm. 2002, 243:135-146.
44. Fessi H., Puisieux F., Devissaguet J.P., Ammoury N., Benita S. Nanocapsules formation by interfacial deposition following solvent displacement. Int. J. Pharm. 1989, 55:R1-R4.
45. Peltonen L., Hirvonen J., Yliruusi J. The behavior of sorbitan surfactants at the water-oil interface: straight-chained hydrocarbons from pentane to dodecane as an oil phase. J. Colloid Interface Sci. 2001, 240:272-276.
46. Mosqueira V.C.F., Legrand P., Gulik A., Bourdon O., Gref R., Labarre D., Barratt G. Relationship between complement activation, cellular uptake and surface physicochemical aspects of novel PEG-modified nanocapsules. Biomaterials 2001, 22:2967-2979.